Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study

Podobne knjige/članki

• Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial
  od: Huss, Michael, et al.
  Izdano: (2014)
• Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
  od: Huss, Michael, et al.
  Izdano: (2013)
• Effect of long-term treatment of hyperactive children with methylphenidate.
  od: Weiss, G., et al.
  Izdano: (1975)
• Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
  od: Coghill, David, et al.
  Izdano: (2013)
• Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
  od: Coghill, David, et al.
  Izdano: (2015)